Japan to India: Vati Import Trade Route

The Japan to India Vati corridor is one of India's established pharmaceutical import routes from Japan, with 12 shipments documented worth a combined $1.2M USD. The route is dominated by EISAI CO. LTD. , which alone accounts for roughly 43% of all import value, reflecting the consolidated nature of Japan's vati export sector.

Across 3 active Japan suppliers, the average shipment value stands at $98.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with vati's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 14.1%, placing it at rank #17 among India's top vati import origins globally.

On the Indian buyer side, key Indian importers include EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED , EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED. EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED is the single largest Indian importer with 9 shipments valued at $930.4K USD.

India's vati imports from Japan are driven primarily by a handful of large-scale Japan manufacturers. EISAI CO. LTD. with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — Indian buyers benefit from Japan supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EISAI CO. LTD. , EISAI CO. LTD., EISAI CO. LIMITED — together account for 100% of total trade value on this route. The average shipment value of $98.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as lenvatinib capsules 4mg, 10caps/blister,2blisters (20caps)/box (lenvima) lot no.138721 (5900 boxes) and lenvatinib capsules 4mg, 10caps/blister,2blisters (20caps)/box (lenvima) lot no.141649 (4660 boxes) , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Japan supplier.

On the buying side, EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED is the largest importer with 9 shipments worth $930.4K USD — representing 79% of all vati imports from Japan on this route.